| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/06/2009 | WO2009096526A1 Carboxylic acid compound or salt thereof |
| 08/06/2009 | WO2009096505A1 Agent for improving attention and concentration powers |
| 08/06/2009 | WO2009096503A1 Benzyl phenyl glucopyranoside derivative |
| 08/06/2009 | WO2009096487A1 Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising the liposome preparation |
| 08/06/2009 | WO2009096445A1 Nerve trunk cell propagation accelerator |
| 08/06/2009 | WO2009096435A1 Condensed heterocyclic derivatives and uses thereof |
| 08/06/2009 | WO2009096377A1 Combined use of angiogenesis inhibitor and taxane |
| 08/06/2009 | WO2009096349A1 Crystalline cinnamide compounds or salts thereof |
| 08/06/2009 | WO2009096245A1 Pharmaceutical composition and combined agent |
| 08/06/2009 | WO2009096196A1 Method for determination of sensitivity to anti-cancer agent |
| 08/06/2009 | WO2009096080A1 Piperidine derivative |
| 08/06/2009 | WO2009061841A3 Modified polynucleotides as antidotes to antisense compounds |
| 08/06/2009 | WO2008079897A3 Macromolecular conjugates of cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof |
| 08/06/2009 | WO2008073961A8 Compounds and methods for modulating the silencing of a polynucleotide of interest |
| 08/06/2009 | WO2002074782A3 Isolation and purification procedure of vasopeptidase peptide inhibitors |
| 08/06/2009 | US20090199306 Fucosyl transferase gene |
| 08/06/2009 | US20090198061 Camptothecin analogs and methods of preparation thereof |
| 08/06/2009 | US20090197973 Method for preparing emulsion or dispersion, and foodstuff, skin externals and medicaments containing emulsion or dispersion obtained by the method |
| 08/06/2009 | US20090197965 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 08/06/2009 | US20090197943 Flavonoid Dimers and Methods of Making and Using Such |
| 08/06/2009 | US20090197813 Methods for treating FSH related conditions with GnRH antagonists |
| 08/06/2009 | US20090197810 Alpha conotoxin peptides with analgesic properties |
| 08/06/2009 | US20090197802 Analogues of GLP-1 |
| 08/06/2009 | US20090197337 Methods for the production of multimeric proteins and related compositions |
| 08/06/2009 | US20090196902 Biogenerator constructed using live cell cultures |
| 08/06/2009 | US20090196898 Stabilized, sterilized collagen scaffolds with active adjuncts attached |
| 08/06/2009 | US20090196879 B-cell depleting agents, like anti-CD20 antibodies or fragments thereof for the treatment of chronic fatigue syndrome |
| 08/06/2009 | US20090196860 Isolated Primate Embryonic Cells and Methods of Generating and Using Same |
| 08/06/2009 | US20090196832 Novel edible aqueous aerosol foam |
| 08/06/2009 | CA2713930A1 Combined use of angiogenesis inhibitor and taxane |
| 08/06/2009 | CA2713677A1 Method for production of orally rapidly disintegrating tablet comprising imidafenacin as active ingredient |
| 08/06/2009 | CA2713673A1 Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising the liposome preparation |
| 08/06/2009 | CA2713571A1 Pharmaceutical composition or combination drug |
| 08/06/2009 | CA2713296A1 Method for determination of sensitivity to anti-cancer agent |
| 08/06/2009 | CA2713293A1 Piperidine derivative |
| 08/06/2009 | CA2712095A1 Crystalline cinnamide compounds or salts thereof |
| 08/05/2009 | EP2085379A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 08/05/2009 | EP2085094A2 Application of aminopeptidases inhibitors and pharmaceutical preparations containing same |
| 08/05/2009 | EP2085093A1 Preparation containing highly purified botulinum toxin type a derived from infant botulism pathogen |
| 08/05/2009 | EP2085090A2 Inhibitors of DNA immunostimulatory sequence activity |
| 08/05/2009 | EP2085087A1 Prodrugs of gaba analogs, compositions and uses thereof |
| 08/05/2009 | EP2083811A1 Methods of treating mental retardation, down's syndrome, fragile x syndrome and autism |
| 08/05/2009 | EP1635799B1 Pharmaceutical formulations of amyloid inhibiting compounds |
| 08/05/2009 | EP1509506B1 Pyridazine derivatives |
| 08/05/2009 | EP1503778B1 Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent |
| 08/05/2009 | EP1501797B1 3-(substituted amino)-1h-indole-2-carboxylic acid ester and 3-(substituted amino)-benzo[b]thiophene-2-carboxylic acid ester derivatives as interleukin-4 gene expression inhibitors |
| 08/05/2009 | EP1496052B1 Novel aminobenzamide derivative |
| 08/05/2009 | EP1491534B1 Novel hairpin polyamide |
| 08/05/2009 | EP1473289B1 Preventives or remedies for alzheimer's disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds |
| 08/05/2009 | EP1465880B1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use to treat disorders associated with somatostatine |
| 08/05/2009 | EP1461313B1 Human adam-10 inhibitors |
| 08/05/2009 | EP1445253B1 4,4-difluoro-1, 2, 3, 4-tetrahydro-5h-1-benzazepine derivatives or salts thereof |
| 08/05/2009 | EP1442115B1 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 08/05/2009 | EP1430085B1 Leukocyte inactivation module |
| 08/05/2009 | EP1430040B1 Benzothiazepine derivatives |
| 08/05/2009 | EP1383731B1 Biaryl compounds as serine protease inhibitors |
| 08/05/2009 | EP1357111B1 2-pyridone derivatives having affinity for cannabinoid type 2 receptor |
| 08/05/2009 | EP1296974B1 2-cyanopyrrolidine derivatives and their use as medicaments |
| 08/05/2009 | EP1249233B9 Npyy5 antagonists |
| 08/05/2009 | EP1210115B1 DOSAGES FOR TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 08/05/2009 | EP1186594B1 N-alkoxyalkyl-n,n-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
| 08/05/2009 | CN101501193A Methods and means for treating DNA repeat instability associated genetic disorders |
| 08/05/2009 | CN101501026A Protein kinase C activity enhancer containing alkyl ether derivative or salt thereof |
| 08/05/2009 | CN101500610A Anti-obesity agent and use thereof |
| 08/05/2009 | CN101500609A Hematopoietic stem cell proliferation promoter |
| 08/05/2009 | CN101500565A Modulators of muscarinic receptors |
| 08/05/2009 | CN101500563A Cycloalkanopyrolocarbazole derivatives and the use thereof as PARP, VEGFR2 and MLK3 inhibitors |
| 08/05/2009 | CN101500559A Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation |
| 08/05/2009 | CN101497570A Salvianolic acid A amino-acid salt, preparation, powder injection composition and use |
| 08/05/2009 | CN101496828A Use of total saponin extract of fenugreek |
| 08/05/2009 | CN101496812A Compositional agent for rapid healing large-sized Acipenser sinensis with serious injury |
| 08/05/2009 | CN100523215C RNA interference mediating small RNA molecules |
| 08/05/2009 | CN100523187C Modified chimeric polyeptides with improved pharmacokinetic properties |
| 08/05/2009 | CN100522991C Peptidomimetic protease inhibitors |
| 08/05/2009 | CN100522984C Steroid compounds having contraceptive and anti-osteoporosis activity |
| 08/05/2009 | CN100522976C Novel azacyclic ethynyl derivatives |
| 08/05/2009 | CN100522972C Fused heterocyclic isoxazoline derivatives and their use as anti-depressants |
| 08/05/2009 | CN100522969C Process for producing flavone C glycoside derivatives |
| 08/05/2009 | CN100522961C Amide substituted xanthine derivatives with gluconeogenesis modulating activity |
| 08/05/2009 | CN100522955C Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 08/05/2009 | CN100522954C Kappa-opioid receptor agonist composed of 2-phenylbenzothiazoline derivative |
| 08/05/2009 | CN100522946C Stabilization of hypoxia inducible factor (HIF) alpha |
| 08/05/2009 | CN100522945C Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and use thereof |
| 08/05/2009 | CN100522940C Derivatives of alpha-phenylthiocarboxylic and g(a)-phenyloxy-carboxylic acids useful for the treatment of diseases responding to PPAR alpha activation |
| 08/05/2009 | CN100522934C Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 08/05/2009 | CN100522921C Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof |
| 08/05/2009 | CN100522249C Elogated and multiple spacers in activatible prodrugs |
| 08/05/2009 | CN100522242C Artificial proteins with reduced immunogenicity |
| 08/05/2009 | CN100522202C Preparation containing lyophilized powder of deer fetus, its preparation method and use |
| 08/05/2009 | CN100522181C Anoxia and fatigue-resisting health-care oxygen, its preparation and use as health-care product |
| 08/05/2009 | CN100522159C The use of substituted azetidinone compounds for the treatment of sitosterolemia |
| 08/05/2009 | CN100522150C Angiogenesis inhibitor |
| 08/05/2009 | CN100522135C Inhalation kit comprisung inhalable powder of tiotropium |
| 08/04/2009 | US7569724 Antiproliferative agnets; anticancer agents; skin disorders |
| 08/04/2009 | US7569706 Chemically modifying a physiologically active polypeptide; improving the stability or water solubility |
| 08/04/2009 | US7569678 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 08/04/2009 | US7569666 Polypeptides associated with activatory receptors and their biological applications |
| 08/04/2009 | US7569609 Treating Alzheimer's disease with 2-propylpentanoic acid (valproic acid) or salts thereof; improving the GABAA receptor responses |
| 08/04/2009 | US7569608 Pentanoic acid derivatives |
| 08/04/2009 | US7569592 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |